Key statistics
On Friday, Myriad Genetics Inc (MYGN:NSQ) closed at 4.49, 19.41% above the 52 week low of 3.76 set on Aug 01, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 4.52 |
|---|---|
| High | 4.71 |
| Low | 4.46 |
| Bid | -- |
| Offer | -- |
| Previous close | 4.53 |
| Average volume | 1.05m |
|---|---|
| Shares outstanding | 93.21m |
| Free float | 90.59m |
| P/E (TTM) | -- |
| Market cap | 418.53m USD |
| EPS (TTM) | -4.34 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
- Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
- Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data
- Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance
- Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference
- Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium
- Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health
- Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
- Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs
- Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference
- Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
More ▼
